The aim of these guidelines is to set-up and standardize diagnostic as well as therapeutic approaches to patients suffering from congenital haemophilia and factor VIII or factor IX inhibitors. Update of the original consensual guidelines is based on evolution in our experience and reflects new available data as well as the advent of new drugs revolutionising our therapeutic approach.